A detailed history of Winton Group LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Winton Group LTD holds 3,584 shares of MRNA stock, worth $235,648. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,584
Holding current value
$235,648
% of portfolio
0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$101.21 - $166.61 $362,736 - $597,130
3,584 New
3,584 $425,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $82,044 - $107,745
851 Added 35.18%
3,270 $337,000
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $604,231 - $818,542
-5,099 Reduced 67.82%
2,419 $293,000
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $441,708 - $641,497
-3,256 Reduced 30.22%
7,518 $1.15 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $3.46 Million - $6.14 Million
-29,228 Reduced 73.07%
10,774 $1.94 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $456,812 - $751,282
3,869 Added 10.71%
40,002 $4.73 Million
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $2.15 Million - $3.24 Million
18,349 Added 103.18%
36,133 $5.16 Million
Q1 2022

May 11, 2022

BUY
$126.46 - $235.05 $1.15 Million - $2.14 Million
9,094 Added 104.65%
17,784 $3.06 Million
Q4 2021

Feb 10, 2022

BUY
$225.82 - $368.51 $989,769 - $1.62 Million
4,383 Added 101.76%
8,690 $2.21 Million
Q3 2021

Oct 28, 2021

SELL
$221.9 - $484.47 $105,402 - $230,123
-475 Reduced 9.93%
4,307 $1.66 Million
Q2 2021

Aug 10, 2021

SELL
$129.91 - $234.98 $688,133 - $1.24 Million
-5,297 Reduced 52.55%
4,782 $1.12 Million
Q1 2021

Jul 21, 2021

SELL
$109.18 - $185.98 $353,415 - $602,017
-3,237 Reduced 24.31%
10,079 $1.32 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $1.77 Million - $4.57 Million
-26,916 Reduced 66.9%
13,316 $1.39 Million
Q3 2020

Oct 30, 2020

BUY
$54.34 - $94.85 $2.19 Million - $3.82 Million
40,232 New
40,232 $2.85 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.